As activation of MEK/ERK1/2 pathway usually facilitates GBM mesenchymal transition and progression [44], it is reasonable to hypothesis that PBX3 promotes GBM mesenchymal transition via activation of MER/ERK1/2. Here, PBX3 is linked to glioblastoma.